SC 13D Filing

Company

KIORA PHARMACEUTICALS INC

Filed

April 23, 2018

Accession Number

0000919574-18-003137

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →